Evidence map›Paper›PMID 36808718›Full record

ArticleAdvanced healthcare materials2023

Engineering of an Osteoinductive and Growth Factor-Free Injectable Bone-Like Microgel for Bone Regeneration.

Ramesh Subbiah, Edith Y Lin, Avathamsa Athirasala, Genevieve E Romanowicz, Angela S P Lin, Joseph V Califano, Robert E Guldberg, Luiz E Bertassoni

Open access · greenAbstract read
In one paragraph

Article in Advanced healthcare materials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ramesh SubbiahDivision of Biomaterials and Biomechanics, Department of Restorative Dentistry, School of Dentistry, Oregon Health and Science University, Portland, OR, 97201, USA.ORCID 0000-0003-0044-9740
Edith Y LinDepartment of Periodontics, School of Dentistry, Oregon Health and Science University, Portland, OR, 97201, USA.
Avathamsa AthirasalaDivision of Biomaterials and Biomechanics, Department of Restorative Dentistry, School of Dentistry, Oregon Health and Science University, Portland, OR, 97201, USA.ORCID 0000-0002-2908-9403
Genevieve E RomanowiczKnight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR, 97403, USA.ORCID 0000-0002-4483-7895
Angela S P LinKnight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR, 97403, USA.
Joseph V CalifanoDepartment of Periodontics, School of Dentistry, Oregon Health and Science University, Portland, OR, 97201, USA.
Robert E GuldbergKnight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR, 97403, USA.ORCID 0000-0002-0303-261X
Luiz E BertassoniDivision of Biomaterials and Biomechanics, Department of Restorative Dentistry, School of Dentistry, Oregon Health and Science University, Portland, OR, 97201, USA.ORCID 0000-0003-2732-8164
Oregon Health & Science University · USUniversity of Oregon · US

Funding

Microengineering vascularized and innervated bone-like scaffolds as an alternative to autologous bone graftsR01DE029553 · NIDCR · OREGON HEALTH & SCIENCE UNIVERSITY · PI BERTASSONI, LUIZ EDUARDO · 2021 to 2025
$3.0M
Microengineering the Dental Pulp Vascular Microenvironment_Diversity SupplementR01DE026170 · NIDCR · OREGON HEALTH & SCIENCE UNIVERSITY · PI BERTASSONI, LUIZ EDUARDO · 2016 to 2020
$2.5M
PORT (Portland Oral health Research Training)T90DE030859 · NIDCR · OREGON HEALTH & SCIENCE UNIVERSITY · PI WU, HUI · 2021 to 2025
$2.1M
An organ-on-a-chip model system to study prostate cancer metastasis into vascularized boneR21CA263860 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI BERTASSONI, LUIZ EDUARDO, MORAN, AMY E · 2022 to 2023
$392k
NIDCR NIH HHS R01 DE026170NIDCR NIH HHS R01 DE029553NIDCR NIH HHS T90 DE030859
6 · The paper itself

Abstract

Bone autografts remain the gold standard for bone grafting surgeries despite having increased donor site morbidity and limited availability. Bone morphogenetic protein-loaded grafts represent another successful commercial alternative. However, the therapeutic use of recombinant growth factors has been associated with significant adverse clinical outcomes. This highlights the need to develop biomaterials that closely approximate the structure and composition of bone autografts, which are inherently osteoinductive and biologically active with embedded living cells, without the need for added supplements. Here, injectable growth factor-free bone-like tissue constructs are developed, that closely approximate the cellular, structural, and chemical composition of bone autografts. It is demonstrated that these micro-constructs are inherently osteogenic, and demonstrate the ability to stimulate mineralized tissue formation and regenerate bone in critical-sized defects in-vivo. Furthermore, the mechanisms that allow human mesenchymal stem cells (hMSCs) to be highly osteogenic in these constructs, despite the lack of osteoinductive supplements, are assessed, whereby Yes activated protein (YAP) nuclear localization and adenosine signaling appear to regulate osteogenic cell differentiation. The findings represent a step toward a new class of minimally invasive, injectable, and inherently osteoinductive scaffolds, which are regenerative by virtue of their ability to mimic the tissue cellular and extracellular microenvironment, thus showing promise for clinical applications in regenerative engineering.

Indexed as

MicrogelsBiocompatible MaterialsBone and BonesBone RegenerationCell DifferentiationHumansOsteogenesisTissue EngineeringTissue ScaffoldsBiocompatible MaterialsMicrogelsadenosine signalingbiomineralizationmechanotransductionosteogenesisregenerative medicinestem cells

Identifiers

PMID36808718
PMCPMC10978434
OpenAlexW4321366422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.